Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2026 Earnings Call Transcript
Operator: Hello, and thank you for standing by. My name is Mel, and I will be your conference operator for today.
Pulse Biosciences Inc. (PLSE)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Portolan Capital Management George Mccabe | 733,372 | $15,833,501 | +87% | 0.84% |
| 2. | Balyasny Asset Management Dmitry Balyasny | 265,164 | $5,724,891 | 0.01% | |
| 3. | LMR Partners Ben Levine, Andrew Manuel And Stefan Renold | 213,137 | $4,601,628 | 0.01% | |
| 4. | Citadel Investment Group Ken Griffin | 142,150 | $3,069,019 | +243% | 0% |
| 5. | Panoramic Capital William R. Hazen | 58,054 | $1,253,386 | +53% | 0.88% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $19.69 | 660,233 | $12,999,987.77 | 48,370,047 | 2026-05-11 | Filing | |
| $19.69 | 15,000 | $295,350.00 | 15,846 | 2026-05-11 | Filing | |
| $19.69 | 15,000 | $295,350.00 | 15,000 | 2026-05-11 | Filing | |
| $19.69 | 660,233 | $12,999,987.77 | 48,211,433 | 2026-05-11 | Filing | |
| $14.41 | 145,140 | $2,091,467.40 | 47,709,140 | 2024-09-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.64 | 5,000 | $118,200.00 | 43,298 | 2026-02-18 | Filing | |
| $23.63 | 20,000 | $472,600.00 | 43,298 | 2026-02-17 | Filing | |
| $23.53 | 20,000 | $470,600.00 | 43,298 | 2026-02-13 | Filing | |
| $23.37 | 20,000 | $467,400.00 | 43,298 | 2026-02-12 | Filing | |
| $25.20 | 20,000 | $504,000.00 | 43,298 | 2026-02-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,339,778 | $28,925,807 | 0% | |
| 2. | 815,852 | $17,614,245 | 0% | |
| 3. | 491,946 | $10,623,020 | 0% | |
| 4. | 462,899 | $9,993,989 | 0% | |
| 5. | 456,927 | $9,865,054 | 0% |
News See All
8 Must-Buy Small Cap Stocks to Buy
After many years of large capitalization companies dominating the US equities market, time is ripe for rotation.
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Colby, and I will be your conference operator today.
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q3 2025 Earnings Call Transcript
Operator: Hello, and thank you for standing by. My name is Mark, and I will be your conference operator today.
Pulse Biosciences, Inc. (PLSE) Advances Cardiac Care with FDA-Approved Atrial Fibrillation Trial
Pulse Biosciences, Inc. (NASDAQ:PLSE) is advancing bioelectric medicine through its proprietary Nano-Pulse Stimulation (NPS) technology, targeting immuno-oncology, dermatology, and cardiac ablation.
12 Healthcare Stocks with Insider Buying in 2025
In 2025, there will be a complicated combination of opportunities and difficulties in the healthcare innovation landscape, with divergent trends in technology adoption, investment, and fundraising.
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q2 2025 Earnings Call Transcript
Operator: Thank you for standing by. Hello, and welcome to the Pulse Biosciences Second Quarter 2025 Earnings Conference Call. Please note that this call is being recorded.
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Pulse Biosciences First Quarter 2025 Financial Results Conference Call. At this time all lines are in listen-only mode.
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Louella, and I will be your conference operator today.
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q3 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Pulse Biosciences' Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Hedge Fund Resource Center